In this study, we sought to further test the hypothesis that increased levels of total tau and 4R tau mRNA in post-mortem human brain tissue are associated with PSP, and if there are differences based on regional vulnerability. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.